Williams v. Brown

CourtDistrict Court, D. Oregon
DecidedOctober 19, 2021
Docket6:21-cv-01332
StatusUnknown

This text of Williams v. Brown (Williams v. Brown) is published on Counsel Stack Legal Research, covering District Court, D. Oregon primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Williams v. Brown, (D. Or. 2021).

Opinion

IN THE UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF OREGON

EUGENE DIVISION

JOSHUA WILLIAMS; JENNIFER Civ. No. 6:21-cv-01332-AA LEWIS; MICHAEL MILLER; PHILLIP KEARNEY; JAY HICKS; JANNA COCHRAN; JULIE ANN SUDERMAN,

Plaintiffs, OPINION & ORDER v.

KATE BROWN; PATRICK ALLEN; OREGON HEALTH AUTHORITY,

Defendants. _______________________________________

AIKEN, District Judge.

This case comes before the Court on Plaintiffs’ Emergency Motion for Temporary Restraining Order. ECF No. 11. The Court heard oral argument on October 18, 2021 by telephone. ECF No. 19. For the reasons set forth below, the motion is DENIED. LEGAL STANDARD “In deciding whether to grant a motion for a temporary restraining order (“TRO”), courts look to substantially the same factors that apply to a court’s decision on whether to issue a preliminary injunction. Pacific Kidney & Hypertension, LLC v. Kassakian, 156 F. Supp.3d 1219. 1222 (D. Or. 2016). A preliminary injunction is an “extraordinary remedy that may only be awarded upon a clear showing that the plaintiff is entitled to such relief.” Winter v. Nat. Res. Def. Council, Inc., 555 U.S. 7, 22 (2008). A plaintiff seeking a preliminary injunction must show (1) that he or she

is likely to succeed on the merits; (2) he or she is likely to suffer irreparable harm in the absence of preliminary relief; (3) the balance of the equities tips in his or her favor; and (4) an injunction is in the public interest. Id. at 20. In the Ninth Circuit, courts may apply an alternative “serious questions” test, which allows for a preliminary injunction where a plaintiff shows that “serious questions going to the merits” were raised and the balance of hardships tips sharply in plaintiff’s favor, assuming the other two elements of the Winter test are met.

Alliance for the Wild Rockies v. Cottrell, 632 F.3d 1127, 1131-32 (9th Cir. 2011). This formulation applies a sliding scale approach where a stronger showing of one element may offset a weaker showing in another element. Id. at 1131. Nevertheless, the party requesting a preliminary injunction must carry its burden of persuasion by a “clear showing” of the four elements set forth above. Lopez v. Brewer, 680 F.3d 1068, 1072 (9th Cir. 2012).

BACKROUND I. COVID-19 and the Vaccines COVID-19 is an infectious disease caused by the virus SARS CoV-2. Sutton Decl. ¶ 4.1 ECF No. 14. COVID-19 is highly transmissible, primarily through

1 Dr. Melissa Sutton is the Medical Director of Respiratory Viral Pathogens in the Public Health Division of the Oregon Health Authority. Sutton Decl. ¶ 1. Dr. Sutton is a board-certified physician with a master’s degree in public health in epidemiology in addition to her medical doctorate. Id. at ¶ 2. Plaintiffs have not submitted any contrary declaration by a medical expert. In support of their respiratory droplet transmission. Id. at ¶¶ 4-6. The virus also mutates as it replicates and produces variants which “may have characteristics of public health consequence, such as evidence of increased transmissibility, evidence of increased

disease severity, and reduced effectiveness of diagnostics, treatments, or vaccines.” Id. at ¶ 7. In June 2021, the Delta variant of the COVID-19 virus emerged as a “variant of concern” and is approximately twice as contagious as earlier variants of the virus. Sutton Decl. ¶ 7. As of October 7, 2021, the U.S. Centers for Disease Control and Prevention (“CDC”) have confirmed more than 43.9 million cases of COVID-19 in the United States, and 707,065 people have died of COVID-19. Id. at ¶ 9. In Oregon, the

CDC reports that there have been 338,130 cases of COVID-19 and 3,900 Oregonians have died of the disease as of October 6, 2021. Id. The number of COVID-19 cases peaked in Oregon in August and September of 2021 with more than 1,178 Oregonians hospitalized with COVID-19 on September 1, 2021. Id. at ¶¶ 8-10. “This represented a more than two-fold increase over the previous peak of 584 on November 30, 2020.” Id. at ¶ 10.

The surge in COVID-19 cases put enormous pressure on Oregon’s medical resources and infrastructure. “Caring for this large number of patients with COVID-

Reply, Plaintiffs submitted a Declaration by their counsel, which included an attached exhibit of a document filed in Zywicki v. Gregory Washington et al., Case No. 1:21-cv-00894-AJT-MSN in U.S. District Court for the Eastern District of Virginia. ECF No. 18. This document does not meet the requirements for an affidavit or declaration as set forth in Local Rule 10-3 in that it is unsigned, not filed separately, and does not present itself as being offered under penalty of perjury. The Court’s review of the docket of the Zywicki matter indicates that this document was originally attached as an exhibit to the complaint in Zywicki and that the Zywicki case was voluntarily dismissed on August 20, 2021, approximately two weeks after it was filed. 19 along with other patients presenting for care has strained the ability of hospitals to provide care for everyone, forcing most to postpone non-urgent care, and leaving many people in Oregon suffering as they wait for non-urgent procedures, such as hip

transplants.” Sutton Decl. ¶ 10. Aside from the risk of death, “[i]ndividuals who contract COVID-19 may suffer prolonged illness with severe complications, such as heart attack, stroke, blood clots and respiratory failure as well as long-term post- COVID conditions.” Id. at ¶ 20. “Vaccination remains the most effective tool to reduce the spread of COVID- 19.” Sutton Decl. ¶ 13. “There are currently three safe and highly effective vaccinations available for use in the United States from Pfizer BioNTech, Moderna

and Johnson & Johnson/Janssen.” Id. at ¶ 11. The Pfizer vaccine was granted official approval by the FDA on August 23, 2021, and the Moderna and Johnson & Johnson vaccines are approved under an emergency use authorization for individuals 18 years of age and older. Id. The CDC recommends that all individuals aged 12 and older be vaccinated against COVID-19. Id. “Vaccines protect individuals who are vaccinated as well as those around them as vaccinated individuals are much less likely to become

infected with COVID-19 and transmit this infection to others,” which “is especially important when the surrounding individuals are unvaccinated such as children younger than 12 years of age who are not yet eligible for COVID-19 vaccinations or individuals at high risk of complications because of underlying medical conditions.” Id. at ¶ 13. “Unvaccinated individuals exposed to COVID-19 are very likely to become infected in the absence of mitigation measures and may then transmit the virus to others,” while “[f]ully vaccinated people get COVID-19 (known as vaccine

breakthrough infections) much less often than unvaccinated people.” Sutton Decl. ¶ 7. In Oregon, 70% of adults have been vaccinated, which substantially reduced the number of COVID-19 deaths during the surge in cases observed in August and September of 2021. Id. at ¶10. An additional 5.8% of Oregonians have received one dose of either the Moderna or Pfizer vaccine but have not yet received the second dose and are considered partially vaccinated. Id. at ¶ 15. There are adequate supplies available to vaccinate all eligible Oregonians. Id. at ¶ 11.

The vaccines have demonstrated continued effectiveness in protecting against the Delta variant of COVID-19. Sutton Decl. ¶ 12. “While hospitalizations and deaths soared among those not fully vaccinated, individuals who were fully vaccinated made up only a small percentage of hospitalizations and deaths during the current surge of cases in Oregon.” Id. at ¶ 13.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Jacobson v. Massachusetts
197 U.S. 11 (Supreme Court, 1905)
City of Cleburne v. Cleburne Living Center, Inc.
473 U.S. 432 (Supreme Court, 1985)
Nordlinger v. Hahn
505 U.S. 1 (Supreme Court, 1992)
Washington v. Glucksberg
521 U.S. 702 (Supreme Court, 1997)
County of Sacramento v. Lewis
523 U.S. 833 (Supreme Court, 1998)
Sierra On-Line, Inc. v. Phoenix Software, Inc.
739 F.2d 1415 (Ninth Circuit, 1984)
Steven J. Harris v. County of Riverside
904 F.2d 497 (Ninth Circuit, 1990)
Samuel Lopez v. Janice Brewer
680 F.3d 1068 (Ninth Circuit, 2012)
Sylvia Landfield Trust v. City of Los Angeles
729 F.3d 1189 (Ninth Circuit, 2013)
Shanks v. Dressel
540 F.3d 1082 (Ninth Circuit, 2008)
Drakes Bay Oyster Company v. Sally Jewell
747 F.3d 1073 (Ninth Circuit, 2013)
Leslie Feldman v. Arizona Sec'y of State's Ofc.
843 F.3d 366 (Ninth Circuit, 2016)
Rosales-Mireles v. United States
585 U.S. 129 (Supreme Court, 2018)
Trump v. Hawaii
585 U.S. 667 (Supreme Court, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
Williams v. Brown, Counsel Stack Legal Research, https://law.counselstack.com/opinion/williams-v-brown-ord-2021.